Dalteparin Sodium — Drug Intelligence | 11 EU Trials

Filter these 11 trials by condition, phase, country and more.

Open in Search →

11 Registered trials

7 Recruiting

2 Completed trials

10 Sponsors

15 Countries

Phase III

Phase IV

Phase III: 4 Phase II/III: 1 Phase II: 1 Phase IV: 5

Oversight events:

1 serious breach across 1 trial

View oversight register →

Indications tested

Intensive care 1 Pulmonary embolism 1 Joint stabilisation 1

Sponsors using this IMP

Rigshospitalet 2 Academisch Ziekenhuis Leiden 1 Akershus University Hospital 1 Anthos Therapeutics Inc. 1 Assistance Publique Hopitaux De Paris 1 Centre Hospitalier Universitaire D'Angers 1 Centre Hospitalier Universitaire De Saint Etienne 1 Institut Gustave Roussy 1 Oslo University Hospital HF 1 Region Hovedstaden 1

All trials

11 total

PALETTE - Trial for personalisation of sepsis treatment in children and adults Pending

2025-521371-31-00 Phase II 1 country Assistance Publique Hopitaux De Paris
Pulmonary Embolism & Anticoagulation Evaluation in Cancer Patient - PEACE Pending

2025-524110-28-00 Phase IV 1 country Region Hovedstaden
The Intensive Care Platform Trial (INCEPT) Recruiting

2024-516208-41-00 Phase IV 5 countries Rigshospitalet
Antiplatelet therapy added to standard thromboprophylaxis to prevent thrombosis in pancreatic cancer patients - a randomized clinical trial … Recruiting

2023-509022-22-00 Phase III 1 country Akershus University Hospital
DISTINCT: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or t… Recruiting

2023-510186-98-00 Phase IV 1 country Academisch Ziekenhuis Leiden
RIVACAST - RIVAroxaban versus low-molecular weight heparin in patients with lower limb trauma requiring brace or CASTing Recruiting

2023-509905-62-00 Phase III 1 country Centre Hospitalier Universitaire D'Angers
Study evaluating thromboprophylaxis in patients with advanced germ cell tumours of good or intermediate prognosis Recruiting

2022-502426-41-00 Phase III 1 country Institut Gustave Roussy
Best Antithrombotic Therapy in patients with acute Venous ThromboEmbolism while taking antiplatelets: the BAT-VTE Recruiting

2022-500974-33-00 Phase III 1 country Centre Hospitalier Universitaire De Saint Etienne
Pre- vs. postoperative thromboprophylaxis for liver resection – a prospective, multicentre, randomized controlled trial (PREPOSTEROUS trial) Recruiting

2024-519726-20-00 Phase IV 1 country Oslo University Hospital HF
A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to dalteparin … Ended

2024-513992-42-00 Phase II/III 12 countries Anthos Therapeutics Inc.
Cluster randomised trial of blood thinners Ended

2022-502402-32-00 Phase IV 1 country Rigshospitalet

Showing 1–11 of 11 trials

← All drugs A–Z